Published in Annu Rev Biophys Biomol Struct on January 01, 2001
Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci (2007) 5.02
Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal (2009) 3.19
The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr (2008) 3.06
Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal (2009) 1.80
Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). Mol Pharmacol (2005) 1.43
An analysis of core deformations in protein superfamilies. Biophys J (2004) 1.33
Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res (2003) 1.30
X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J (2001) 1.27
Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab (2008) 1.21
Molecular origins for the dominant negative function of human glucocorticoid receptor beta. Mol Cell Biol (2003) 1.17
Functional evolution of the vitamin D and pregnane X receptors. BMC Evol Biol (2007) 1.17
Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors). Nucl Recept (2005) 1.17
1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth. Mol Cancer Ther (2008) 1.16
Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening. Mol Pharmacol (2008) 1.12
Nuclear receptors as drug targets for metabolic disease. Adv Drug Deliv Rev (2010) 1.10
Retinoid-related Orphan Receptors (RORs): Roles in Cellular Differentiation and Development. Adv Dev Biol (2006) 1.07
Ligand specificity and evolution of liver X receptors. J Steroid Biochem Mol Biol (2008) 1.06
The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites. EMBO J (2010) 1.03
Hsp90--from signal transduction to cell transformation. Biochem Biophys Res Commun (2007) 1.02
A critical role of helix 3-helix 5 interaction in steroid hormone receptor function. Proc Natl Acad Sci U S A (2005) 1.00
Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations. PLoS One (2011) 0.98
Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Mol Cell Endocrinol (2010) 0.97
SPBP is a phosphoserine-specific repressor of estrogen receptor alpha. Mol Cell Biol (2005) 0.96
Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism. Mol Cell Biol (2005) 0.93
c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol Cell Biol (2005) 0.93
The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. BMC Biochem (2011) 0.89
Polycyclic aromatic hydrocarbons (PAHs) mediate transcriptional activation of the ATP binding cassette transporter ABCB6 gene via the aryl hydrocarbon receptor (AhR). J Biol Chem (2012) 0.86
Anti-steroidogenic factor ARR19 inhibits testicular steroidogenesis through the suppression of Nur77 transactivation. J Biol Chem (2010) 0.83
Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch. J Mol Biol (2010) 0.82
The cell-specific activity of the estrogen receptor alpha may be fine-tuned by phosphorylation-induced structural gymnastics. Nucl Recept Signal (2006) 0.82
Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex. Sci Rep (2016) 0.82
Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: an approach for the screening of endocrine disruptors. Protein Sci (2007) 0.81
Understanding nuclear receptors using computational methods. Drug Discov Today (2009) 0.80
Specificity of receptor-ligand interactions and their effect on dimerisation as observed by electrospray mass spectrometry: bile acids form stable adducts to the RXRalpha. J Mass Spectrom (2005) 0.80
Helix 3-helix 5 interactions in steroid hormone receptor function. J Steroid Biochem Mol Biol (2008) 0.78
The loss of transcriptional inhibition by the photoreceptor-cell specific nuclear receptor (NR2E3) is not a necessary cause of enhanced S-cone syndrome. Mol Vis (2007) 0.78
Transforming growth factor-β1 signaling represses testicular steroidogenesis through cross-talk with orphan nuclear receptor Nur77. PLoS One (2014) 0.78
Ab initio fragment molecular orbital study of ligand binding to human progesterone receptor ligand-binding domain. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.77
Equilibrium unfolding of the retinoid X receptor ligand binding domain and characterization of an unfolding intermediate. Biophys Chem (2008) 0.77
Novel Carbonyl Analogs of Tamoxifen: Design, Synthesis, and Biological Evaluation. Front Chem (2017) 0.75
Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis. J Comput Aided Mol Des (2003) 0.75
Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature (1990) 9.21
An attempt to unify the structure of polymerases. Protein Eng (1990) 7.93
Chemical and biological evolution of nucleotide-binding protein. Nature (1974) 7.39
Crystallographic refinement of yeast aspartic acid transfer RNA. J Mol Biol (1985) 6.33
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Class II aminoacyl transfer RNA synthetases: crystal structure of yeast aspartyl-tRNA synthetase complexed with tRNA(Asp). Science (1991) 4.87
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69
Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature (1984) 3.66
Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell (1998) 3.27
Zinc ion mediated amino acid discrimination by threonyl-tRNA synthetase. Nat Struct Biol (2000) 2.97
An operational RNA code for amino acids and possible relationship to genetic code. Proc Natl Acad Sci U S A (1993) 2.87
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell (2000) 2.77
The structure of threonyl-tRNA synthetase-tRNA(Thr) complex enlightens its repressor activity and reveals an essential zinc ion in the active site. Cell (1999) 2.74
Crystal structure of yeast tRNAAsp. Nature (1980) 2.61
Yeast tRNA(Asp) recognition by its cognate class II aminoacyl-tRNA synthetase. Nature (1993) 2.57
Spontaneous assembly of double-stranded helicates from oligobipyridine ligands and copper(I) cations: structure of an inorganic double helix. Proc Natl Acad Sci U S A (1987) 2.57
Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins (2004) 2.51
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell (2000) 2.33
Structural and functional considerations of the aminoacylation reaction. Trends Biochem Sci (1997) 2.22
Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals. Acta Crystallogr A (1988) 2.08
Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell (2000) 2.05
Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1975) 2.05
A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell (2001) 2.02
The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99
tRNA aminoacylation by arginyl-tRNA synthetase: induced conformations during substrates binding. EMBO J (2000) 1.88
Synthesis of aspartyl-tRNA(Asp) in Escherichia coli--a snapshot of the second step. EMBO J (1999) 1.88
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J (2000) 1.86
The aminoacyl-tRNA synthetase family: modules at work. Bioessays (1993) 1.64
D-glyceraldehyde-3-phosphate dehydrogenase: three-dimensional structure and evolutionary significance. Proc Natl Acad Sci U S A (1973) 1.64
Molecular structure of human TFIIH. Cell (2000) 1.64
Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell (1998) 1.63
Crystal structure of Aeromonas proteolytica aminopeptidase: a prototypical member of the co-catalytic zinc enzyme family. Structure (1994) 1.58
Structure determination of crystalline lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 1.57
Structural studies on nuclear receptors. Cell Mol Life Sci (2000) 1.57
The role of the distal histidine in myoglobin and haemoglobin. Nature (1988) 1.55
Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Nature (1992) 1.54
Crystallographic structure of an RNA helix: [U(UA)6A]2. J Mol Biol (1989) 1.53
Crystal structure of glycyl-tRNA synthetase from Thermus thermophilus. EMBO J (1995) 1.50
Comparison of the tertiary structure of yeast tRNA(Asp) and tRNA(Phe) in solution. Chemical modification study of the bases. J Mol Biol (1987) 1.50
Solution structure of a tRNA with a large variable region: yeast tRNASer. J Mol Biol (1989) 1.47
TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ (2008) 1.47
The human TFIID components TAF(II)135 and TAF(II)20 and the yeast SAGA components ADA1 and TAF(II)68 heterodimerize to form histone-like pairs. Mol Cell Biol (2000) 1.45
Base-pairing shift in the major groove of (CA)n tracts by B-DNA crystal structures. Nature (1991) 1.42
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J Biol Chem (2000) 1.42
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J (1997) 1.41
The 2.0 A crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules. Structure (2000) 1.40
The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med (Berl) (2001) 1.36
Crystal structure of histidyl-tRNA synthetase from Escherichia coli complexed with histidyl-adenylate. EMBO J (1995) 1.35
The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure (1997) 1.34
Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol (2001) 1.33
L-arginine recognition by yeast arginyl-tRNA synthetase. EMBO J (1998) 1.33
3-D graphics modelling of the tRNA-like 3'-end of turnip yellow mosaic virus RNA: structural and functional implications. J Biomol Struct Dyn (1987) 1.33
The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem Sci (1999) 1.33
Crystal structure of aspartyl-tRNA synthetase from Pyrococcus kodakaraensis KOD: archaeon specificity and catalytic mechanism of adenylate formation. EMBO J (1998) 1.31
A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J (1997) 1.30
The effects of E7 and E11 mutations on the kinetics of ligand binding to R state human hemoglobin. J Biol Chem (1989) 1.29
Conformational adaptation of agonists to the human nuclear receptor RAR gamma. Nat Struct Biol (1998) 1.29
The structure of an AspRS-tRNA(Asp) complex reveals a tRNA-dependent control mechanism. EMBO J (2001) 1.28
X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J (2001) 1.27
Recognition of tRNAs by aminoacyl-tRNA synthetases. FASEB J (1993) 1.27
Unusual helical packing in crystals of DNA bearing a mutation hot spot. Nature (1989) 1.26
Coordinated amino acid changes in homologous protein families. Protein Eng (1988) 1.24
Conformational changes and dynamics of tRNAs: evidence from hydrolysis patterns. Cold Spring Harb Symp Quant Biol (1987) 1.23
The first step of aminoacylation at the atomic level in histidyl-tRNA synthetase. Proc Natl Acad Sci U S A (1997) 1.21
Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci U S A (2001) 1.20
Three-dimensional structure of D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 1.19
Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett (2000) 1.17
Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem (2000) 1.16
Sequence, overproduction and crystallization of aspartyl-tRNA synthetase from Thermus thermophilus. Implications for the structure of prokaryotic aspartyl-tRNA synthetases. FEBS Lett (1993) 1.16
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. J Mol Biol (2000) 1.16
Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem (2001) 1.15
Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J Biol Chem (2000) 1.15
Glycyl-tRNA synthetase uses a negatively charged pit for specific recognition and activation of glycine. J Mol Biol (1999) 1.15
Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif (2001) 1.14
Role of dimerization in yeast aspartyl-tRNA synthetase and importance of the class II invariant proline. Proc Natl Acad Sci U S A (1993) 1.12
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 1.12
Dissecting the interaction network of multiprotein complexes by pairwise coexpression of subunits in E. coli. J Mol Biol (2001) 1.12
Groove-backbone interaction in B-DNA. Implication for DNA condensation and recombination. J Mol Biol (1991) 1.11
Crystal structure of a prokaryotic aspartyl tRNA-synthetase. EMBO J (1994) 1.11
Anticodon-anticodon interaction induces conformational changes in tRNA: yeast tRNAAsp, a model for tRNA-mRNA recognition. Proc Natl Acad Sci U S A (1986) 1.11
Solvation of the left-handed hexamer d(5BrC-G-5BrC-G-5 BrC-G) in crystals grown at two temperatures. J Mol Biol (1986) 1.10
Self-fitting and self-modifying properties of the B-DNA molecule. J Mol Biol (1995) 1.10
Retinoic acid receptor: a simulation analysis of retinoic acid binding and the resulting conformational changes. J Mol Biol (1999) 1.10
The contacts of yeast tRNA(Ser) with seryl-tRNA synthetase studied by footprinting experiments. Eur J Biochem (1990) 1.10
Synthesis and recognition of aspartyl-adenylate by Thermus thermophilus aspartyl-tRNA synthetase. J Mol Biol (1994) 1.10
A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure (1997) 1.10
The structure of the Aeromonas proteolytica aminopeptidase complexed with a hydroxamate inhibitor. Involvement in catalysis of Glu151 and two zinc ions of the co-catalytic unit. Eur J Biochem (1996) 1.09
High resolution structure of the RNA duplex [U(U-A)6A]2. Nature (1988) 1.09
Yeast transfer RNAasp: a new high-resolution x-ray diffracting crystal form of a transfer RNA. J Mol Biol (1977) 1.09
The free yeast aspartyl-tRNA synthetase differs from the tRNA(Asp)-complexed enzyme by structural changes in the catalytic site, hinge region, and anticodon-binding domain. J Mol Biol (2000) 1.08
Antagonism in the human mineralocorticoid receptor. EMBO J (1998) 1.08